Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Schaule

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2026
Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysisJustus Kaufmann, Eirini Nikolaidou, Isabel Krabbes, et al.
BJU International|October 28, 2020
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinomaStephanie G C Kroeze, Corinna Fritz, Jana Schaule, et al.
Radiation Oncology (London, England)|January 7, 2021
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' databaseStephanie G C Kroeze, Jana Schaule, Corinna Fritz, et al.
Radiation Oncology (London, England)|December 15, 2020
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic scoreJana Schaule, Stephanie G C Kroeze, Oliver Blanck, et al.
Radiation Oncology (London, England)|June 4, 2020
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic scoreJana Schaule, Stephanie G C Kroeze, Oliver Blanck, et al.
Cancers|October 13, 2021
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy AnalysisStephanie G C Kroeze, Corinna Fritz, Jana Schaule, et al.
JAMA Network Open|January 14, 2026
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer TherapyEsmée L Looman, Stephanie G C Kroeze, Jana Schaule, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2026
Medial retropharyngeal lymph node involvement in nasopharyngeal cancer patients treated with radiotherapy in Germany - A multicenter analysisJustus Kaufmann, Eirini Nikolaidou, Isabel Krabbes, et al.
BJU International|October 28, 2020
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinomaStephanie G C Kroeze, Corinna Fritz, Jana Schaule, et al.
Radiation Oncology (London, England)|January 7, 2021
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' databaseStephanie G C Kroeze, Jana Schaule, Corinna Fritz, et al.
Radiation Oncology (London, England)|December 15, 2020
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic scoreJana Schaule, Stephanie G C Kroeze, Oliver Blanck, et al.
Radiation Oncology (London, England)|June 4, 2020
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic scoreJana Schaule, Stephanie G C Kroeze, Oliver Blanck, et al.
Cancers|October 13, 2021
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy AnalysisStephanie G C Kroeze, Corinna Fritz, Jana Schaule, et al.
JAMA Network Open|January 14, 2026
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer TherapyEsmée L Looman, Stephanie G C Kroeze, Jana Schaule, et al.
Pageof 1